Your browser doesn't support javascript.
loading
Critical considerations for targeting colorectal liver metastases with nanotechnology.
Arshad, Usman; Sutton, Paul A; Ashford, Marianne B; Treacher, Kevin E; Liptrott, Neill J; Rannard, Steve P; Goldring, Christopher E; Owen, Andrew.
Afiliação
  • Arshad U; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Sutton PA; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Ashford MB; AstraZeneca, Advanced Drug Delivery, Pharmaceutical Sciences, R&D, Macclesfield, UK.
  • Treacher KE; AstraZeneca, Pharmaceutical Technology and Development, Macclesfield, UK.
  • Liptrott NJ; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Rannard SP; Department of Chemistry, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
  • Goldring CE; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Owen A; Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, UK.
Article em En | MEDLINE | ID: mdl-31566913

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Sistemas de Liberação de Medicamentos / Nanomedicina / Nanopartículas / Neoplasias Hepáticas Limite: Animals / Humans Idioma: En Revista: Wiley Interdiscip Rev Nanomed Nanobiotechnol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Sistemas de Liberação de Medicamentos / Nanomedicina / Nanopartículas / Neoplasias Hepáticas Limite: Animals / Humans Idioma: En Revista: Wiley Interdiscip Rev Nanomed Nanobiotechnol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido